These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10416603)

  • 1. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas.
    Shinoura N; Yoshida Y; Tsunoda R; Ohashi M; Zhang W; Asai A; Kirino T; Hamada H
    Cancer Res; 1999 Jul; 59(14):3411-6. PubMed ID: 10416603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma.
    Yoshida Y; Sadata A; Zhang W; Saito K; Shinoura N; Hamada H
    Hum Gene Ther; 1998 Nov; 9(17):2503-15. PubMed ID: 9853517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus.
    Ohashi M; Kanai F; Tateishi K; Taniguchi H; Marignani PA; Yoshida Y; Shiratori Y; Hamada H; Omata M
    Biochem Biophys Res Commun; 2001 Mar; 282(2):529-35. PubMed ID: 11401492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
    Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
    Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transduction of a fiber-mutant adenovirus for the HSVtk gene highly augments the cytopathic effect towards gliomas.
    Shinoura N; Sakurai S; Asai A; Kirino T; Hamada H
    Jpn J Cancer Res; 2000 Oct; 91(10):1028-34. PubMed ID: 11050474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
    Geoerger B; Grill J; Opolon P; Morizet J; Aubert G; Terrier-Lacombe MJ; Bressac De-Paillerets B; Barrois M; Feunteun J; Kirn DH; Vassal G
    Cancer Res; 2002 Feb; 62(3):764-72. PubMed ID: 11830531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
    Kim J; Cho JY; Kim JH; Jung KC; Yun CO
    Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas.
    Shinoura N; Yoshida Y; Asai A; Kirino T; Hamada H
    Cancer Gene Ther; 2000 May; 7(5):732-8. PubMed ID: 10830720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically modified adenoviruses against gliomas: from bench to bedside.
    Gomez-Manzano C; Yung WK; Alemany R; Fueyo J
    Neurology; 2004 Aug; 63(3):418-26. PubMed ID: 15304571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas.
    Shinoura N; Muramatsu Y; Nishimura M; Yoshida Y; Saito A; Yokoyama T; Furukawa T; Horii A; Hashimoto M; Asai A; Kirino T; Hamada H
    Cancer Res; 1999 Nov; 59(21):5521-8. PubMed ID: 10554029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel E1A-E1B mutant adenovirus induces glioma regression in vivo.
    Gomez-Manzano C; Balague C; Alemany R; Lemoine MG; Mitlianga P; Jiang H; Khan A; Alonso M; Lang FF; Conrad CA; Liu TJ; Bekele BN; Yung WK; Fueyo J
    Oncogene; 2004 Mar; 23(10):1821-8. PubMed ID: 15014451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.
    Nemunaitis J; Ganly I; Khuri F; Arseneau J; Kuhn J; McCarty T; Landers S; Maples P; Romel L; Randlev B; Reid T; Kaye S; Kirn D
    Cancer Res; 2000 Nov; 60(22):6359-66. PubMed ID: 11103798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.
    Fukuda K; Abei M; Ugai H; Seo E; Wakayama M; Murata T; Todoroki T; Tanaka N; Hamada H; Yokoyama KK
    Cancer Res; 2003 Aug; 63(15):4434-40. PubMed ID: 12907616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene.
    Tsuda H; Wada T; Yamashita T; Hamada H
    J Gene Med; 2005 Oct; 7(10):1322-34. PubMed ID: 15926193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models.
    Staba MJ; Wickham TJ; Kovesdi I; Hallahan DE
    Cancer Gene Ther; 2000 Jan; 7(1):13-9. PubMed ID: 10678351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus lacking the 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cells.
    Duque PM; Alonso C; Sánchez-Prieto R; Lleonart M; Martínez C; de Buitrago GG; Cano A; Quintanilla M; Ramon y Cajal S
    Cancer Gene Ther; 1999; 6(6):554-63. PubMed ID: 10608352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
    Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.